Rhythm Pharmaceuticals Intangible Assets

Rhythm Pharmaceuticals (RYTM) currently reports a intangible assets of $5.1M as of March 2026. That compares with $6M in the prior-year period — down 14.3% year over year. Use the charts on this page to explore Rhythm Pharmaceuticals's intangible assets history and peer comparisons.

Rhythm Pharmaceuticals's intangible assets decreased from $6M to $5.1M — a 14.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rhythm Pharmaceuticals reported $5.1M in intangible assets as of March 2026. That compares with $6M in the prior-year period — down 14.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $5.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rhythm Pharmaceuticals, and consider following RYTM for alerts when major investors trade the stock.

Rhythm Pharmaceuticals is classified in the Healthcare sector. On intangible assets, it currently shows $5.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RYTM with unrelated industries.